Tumor News and Research

RSS

Survey highlights major gap in women’s knowledge about genomic testing in breast cancer

Breast cancer is the most feared type of cancer among women in Germany, according to a recent representative survey commissioned by Agendia, a world leader in personalized medicine and molecular cancer diagnostics.

11 Oct 2017

BU professor receives $792,000 grant to study about aggressiveness of T-ALL

Hui Feng, MD, PhD, assistant professor of pharmacology and medicine at Boston University School of Medicine, is the recipient of a four-year, $792,000 grant from the American Cancer Society to study why T-cell acute lymphoblastic leukemia (T-ALL) is so aggressive and resistant to treatment.

10 Oct 2017

Experts indicate new way via which tumor cells can respond to chemotherapy

An international group of researchers, with the participation of the members of the University of Seville and the Andalusian Centre of Molecular Biology and Regenerative Medicine has just published a study in the prestigious review Science, in which they describe a new methodology for making tumor cells behave when submitted to chemotherapy, which, in the hope of new treatments, continues to be a fundamental tool in the fight against cancer.

10 Oct 2017

Training new doctors right where they’re needed

Dr. Olga Meave didn't mind the dry, 105-degree heat that scorched this Central Valley city on a recent afternoon. The sweltering summer days remind her of home in Sonora, Mexico. So do the people of the Valley — especially the Latino first-generation immigrants present here in large numbers, toiling in the fields or piloting big rigs laden with fruits and vegetables.

9 Oct 2017

UCLA scientists discover potential combination treatment for brain cancer in adults

UCLA scientists have discovered a potential combination treatment for glioblastoma, the deadliest form of brain cancer in adults. The three-year study led by Dr. David Nathanson, a member of UCLA's Jonsson Comprehensive Cancer Center, found that the drug combination tested in mice disrupts and exploits glucose intake, essentially cutting off the tumor's nutrients and energy supply.

9 Oct 2017

Researchers discover mutation that amplifies capabilities of tumor-suppressor protein

Cancer researchers have long hailed p53, a tumor-suppressor protein, for its ability to keep unruly cells from forming tumors. But for such a highly studied protein, p53 has hidden its tactics well.

9 Oct 2017

Researchers develop new diagnostic and prognosis method for early detection of liver cancer

An international team of researchers at University of California San Diego School of Medicine and Moores Cancer Center, with colleagues at Sun Yet-sun University Cancer Center and other collaborating institutions, have developed a new diagnostic and prognosis method for early detection of hepatocellular carcinoma (HCC), based on a simple blood sample containing circulating tumor DNA.

9 Oct 2017

New U-M study examines why overtreatment in older breast cancer patients persists

Recent clinical trials have shown that 90 percent of early stage breast cancer patients over age 70 do not benefit from radiation after breast-conserving surgery. And yet, use of radiation in this context has dropped only minimally.

9 Oct 2017

Study provides insights into non-oncogenic addictions of tumors

Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego have shown that tumors can ensure a more reliable nutrient supply by eliminating the p62 protein in surrounding stromal tissue.

9 Oct 2017

New topical treatment to combat skin cancer yields promising results in preliminary study

Researchers at the University of São Paulo (USP), in Brazil, are testing a technique in mice that combines low-intensity electric current with a formulation containing nanoencapsulated chemotherapy to treat skin cancer.

6 Oct 2017

NTNU professors provide insight into pros and cons of early disease detection

Ever improving medical technology allows doctors to also discover conditions and precursors of disease that may never progress. To be on the safe side, most people still want to receive treatment.

6 Oct 2017

Genetic signature within prostate cancer cells can predict metastatic tumors

Many prostate cancers, which generally are diagnosed in older men, are "indolent," slow-growing tumors that aren't destined to be fatal. But some tumors are prone to becoming aggressive and spreading beyond the prostate, making them difficult to treat and life-threatening.

6 Oct 2017

UC Davis professor wins NIH award to develop ‘smart’ immune cells for cancer therapies

Assistant Professor Sean Collins, Department of Microbiology and Molecular Genetics in the UC Davis College of Biological Sciences, has received a $1.5 million award from the National Institutes of Health to advance the development of "smart" immune cells for therapies to treat cancer and other diseases.

6 Oct 2017

CRI scientists challenge oldest concept in tumor metabolism

Scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) have discovered that lactate provides a fuel for growing tumors, challenging a nearly century-old observation known as the Warburg effect.

6 Oct 2017

New research can help develop better chemotherapy treatments for pancreatic cancer

Tal Danino, a professor at the Data Science Institute, is conducting research that could help scientists combat the most lethal of cancers: pancreatic cancer.

6 Oct 2017

Researchers pinpoint genetic drivers of diffuse large B cell lymphoma

Lymphoma is the most common blood cancer, but the diagnosis belies a wildly diverse and little understood genetic foundation for the disease that hampers successful treatment.

5 Oct 2017

Study provides insight into how cells in the body adapt to nerve injury

Genetic processes that allow cells to transform so they can mend damaged nerves have been identified by scientists.

5 Oct 2017

New app helps doctors make better decisions during brain surgeries

A new app developed by the University of Wisconsin-Milwaukee and the Medical College of Wisconsin helps doctors make better decisions during brain surgeries.

5 Oct 2017

Gene targets for triple negative breast cancers resistant to chemotherapy found

Researchers have finally found the genetic targets that could be used for treatment and development of new drugs in patients who are resistant to chemotherapy. These patients who are resistant to chemotherapy are most likely to have triple negative breast cancer which is the most aggressive form of breast cancer. The study appeared in the latest issue of the journal Cell Metabolism.

4 Oct 2017

UAlberta researchers create new imaging agents to keep track of tumor growth

UAlberta researchers have created two new imaging agents that could help physicians visualize the formation of tumor-associated blood vessels, keep track of tumor growth and possibly generate new therapies.

4 Oct 2017

Tumor News and Research

Survey highlights major gap in women’s knowledge about genomic testing in breast cancer

BU professor receives $792,000 grant to study about aggressiveness of T-ALL

Experts indicate new way via which tumor cells can respond to chemotherapy

Training new doctors right where they’re needed

UCLA scientists discover potential combination treatment for brain cancer in adults

Researchers discover mutation that amplifies capabilities of tumor-suppressor protein

Researchers develop new diagnostic and prognosis method for early detection of liver cancer

New U-M study examines why overtreatment in older breast cancer patients persists

Study provides insights into non-oncogenic addictions of tumors

New topical treatment to combat skin cancer yields promising results in preliminary study

NTNU professors provide insight into pros and cons of early disease detection

Genetic signature within prostate cancer cells can predict metastatic tumors

UC Davis professor wins NIH award to develop ‘smart’ immune cells for cancer therapies

CRI scientists challenge oldest concept in tumor metabolism

New research can help develop better chemotherapy treatments for pancreatic cancer

Researchers pinpoint genetic drivers of diffuse large B cell lymphoma

Study provides insight into how cells in the body adapt to nerve injury

New app helps doctors make better decisions during brain surgeries

Gene targets for triple negative breast cancers resistant to chemotherapy found

UAlberta researchers create new imaging agents to keep track of tumor growth

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News